Dedomenico to Chair TOC Medication Committee
by Blood-Horse Staff
Date Posted: 5/29/2011 3:15:25 PM
Last Updated: 5/30/2011 4:19:37 PM
Dr. Mark Dedomenico has been selected chairman of the Thoroughbred Owners of California's medication and integrity committee by the organization's board of directors, it was announced May 28.
Dedomenico was appointed to the TOC board in February.
“Dr. Mark is a true asset to the TOC board and its membership,” said TOC chairman Jack Owens. “He not only brings us his extensive racing experience, but also a lifetime dedicated to the advancement of equine and human medical treatments.”
A cardiovascular surgeon and researcher, Dedomenico played a key role in the development of coronary bypass surgery and the Guided Flow Aortic Heart Valve and the Bionit Arterial Grafts that are used around the world to replace damaged or atherosclerotic arteries. He is a founding member of Hope Heart Institute in Seattle, Wash., and owns and operates the 45,000-member PRO Sports Health Club where he has carried out extensive research in the field of metabolic disorders such as high cholesterol, hypertension and diabetes, the main cause of heart disease. He is also involved in the research and treatment of obesity.
At his Pegasus Thoroughbred Training and Rehabilitation center in Redmond, Wash., he and Dr. Wayne McIlwraith of Colorado State University are researching new treatments for equine middle and lower knee injuries as well as researching the use of platelet rich plasma and stem cell therapy.
Following in the footsteps of his father, who raced multiple stakes winners on the West Coast for many years, Dedomenico has more than 50 runners in training, including 2010 Eclipse Award champion 3-year-old filly Blind Luck, co-owned with trainer Jerry Hollendorfer and partners John Carver and Peter Abruzzo. He also breeds a limited number of mares.
Dedomenico replaces director Pablo Suarez in the role as chairman of the committee.
Copyright © 2013 The Blood-Horse, Inc. All Rights Reserved.